Tech Company Financing Transactions
NeuMoDx Molecular Funding Round
NeuMoDx Molecular, operating out of Ann Arbor, scored $21 million in investment from Pfizer Venture Investments, Arboretum Ventures and Baird Capital.
Transaction Overview
Company Name
Announced On
4/2/2014
Transaction Type
Venture Equity
Amount
$21,000,000
Round
Series B
Investors
Pfizer Venture Investments (Lead Investor) (William Burkoth)
Proceeds Purpose
This financing will be used to fund development of the NeuMoDx 500 Molecular IVD System, a fully automated, random access platform capable of performing RNA and DNA-based assays.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1250 Eisenhower Pl.
Ann Arbor, MI 48108
USA
Ann Arbor, MI 48108
USA
Phone
Website
Email Address
Overview
NeuMoDx Molecular, Inc. will provide hospital and clinical reference laboratories with a vastly superior solution for in vitro molecular diagnostic (MDx) testing.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeff Williams
President
Sundu Brahmasandra
VP - Bus. Development
Daniel Harma
VP - Marketing
Jason Ong
VP - Regulatory Affairs
Nahed Mohsen
Browse more venture capital transactions:
Prev: 4/2/2014: Pulmonx venture capital transaction
Next: 4/2/2014: Transcend Medical venture capital transaction
Share this article
Where The Data Comes From
We report on funding rounds that are announced publicly. All VC database entries on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs